The US Food and Drug Administration (FDA) has issued Emergency Use Authorisation (EAU) for Subsalve’s oxygen treatment hood, in order to help those suffering from coronavirus.
Subsalve’s oxygen hood is a one-piece, soft, single patient use device used for helmet/hooded non-invasive positive pressure ventilation. The ventilation technique has been used in Italy for decades but is a new treatment for North America.
Until the issued EUA, only off-label use of helmet ventilation had been implemented for treating respiratory distress.
During the pandemic, mortality once intubated has been reported to be as high at 80% in the US. However, with the newly available oxygen treatment hood, physicians can proactively treat early respiratory distress and hypoxemia without incubation.
... to continue reading you must be subscribed
